Biosimilar Monoclonal Antibody Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: BEB1A0705316EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Biosimilar Monoclonal Antibody in Global, including the following market information:

Global Biosimilar Monoclonal Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biosimilar Monoclonal Antibody market was valued at 4706.7 million in 2021 and is projected to reach US$ 24410 million by 2028, at a CAGR of 26.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Limited Dilution Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biosimilar Monoclonal Antibody include Biocon, Accord Healthcare, AET Biotech, Amgen, Celltrion, Reddy's Laboratories, Hospira, 3SBio and Allergan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar Monoclonal Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biosimilar Monoclonal Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biosimilar Monoclonal Antibody Market Segment Percentages, by Type, 2021 (%)

• Limited Dilution Method
• Micromanipulation
• Soft Agar Plate Method
• Others

Global Biosimilar Monoclonal Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biosimilar Monoclonal Antibody Market Segment Percentages, by Application, 2021 (%)

• Chronic & Autoimmune Diseases
• Oncology
• Others

Global Biosimilar Monoclonal Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biosimilar Monoclonal Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biosimilar Monoclonal Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biosimilar Monoclonal Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biocon
• Accord Healthcare
• AET Biotech
• Amgen
• Celltrion
• Reddy's Laboratories
• Hospira
• 3SBio
• Allergan
• Alvartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biosimilar Monoclonal Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biosimilar Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOSIMILAR MONOCLONAL ANTIBODY OVERALL MARKET SIZE

2.1 Global Biosimilar Monoclonal Antibody Market Size: 2021 VS 2028
2.2 Global Biosimilar Monoclonal Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biosimilar Monoclonal Antibody Players in Global Market
3.2 Top Global Biosimilar Monoclonal Antibody Companies Ranked by Revenue
3.3 Global Biosimilar Monoclonal Antibody Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Monoclonal Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Monoclonal Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Players in Global Market
  3.6.1 List of Global Tier 1 Biosimilar Monoclonal Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biosimilar Monoclonal Antibody Market Size Markets, 2021 & 2028
  4.1.2 Limited Dilution Method
  4.1.3 Micromanipulation
  4.1.4 Soft Agar Plate Method
  4.1.5 Others
4.2 By Type - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
  4.2.1 By Type - Global Biosimilar Monoclonal Antibody Revenue, 2017-2022
  4.2.2 By Type - Global Biosimilar Monoclonal Antibody Revenue, 2023-2028
  4.2.3 By Type - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biosimilar Monoclonal Antibody Market Size, 2021 & 2028
  5.1.2 Chronic & Autoimmune Diseases
  5.1.3 Oncology
  5.1.4 Others
5.2 By Application - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
  5.2.1 By Application - Global Biosimilar Monoclonal Antibody Revenue, 2017-2022
  5.2.2 By Application - Global Biosimilar Monoclonal Antibody Revenue, 2023-2028
  5.2.3 By Application - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biosimilar Monoclonal Antibody Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
  6.2.1 By Region - Global Biosimilar Monoclonal Antibody Revenue, 2017-2022
  6.2.2 By Region - Global Biosimilar Monoclonal Antibody Revenue, 2023-2028
  6.2.3 By Region - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biosimilar Monoclonal Antibody Revenue, 2017-2028
  6.3.2 US Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.3.3 Canada Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.3.4 Mexico Biosimilar Monoclonal Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biosimilar Monoclonal Antibody Revenue, 2017-2028
  6.4.2 Germany Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.3 France Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.4 U.K. Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.5 Italy Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.6 Russia Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.4.8 Benelux Biosimilar Monoclonal Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biosimilar Monoclonal Antibody Revenue, 2017-2028
  6.5.2 China Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.5.3 Japan Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.5.4 South Korea Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.5.6 India Biosimilar Monoclonal Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biosimilar Monoclonal Antibody Revenue, 2017-2028
  6.6.2 Brazil Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.6.3 Argentina Biosimilar Monoclonal Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biosimilar Monoclonal Antibody Revenue, 2017-2028
  6.7.2 Turkey Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.7.3 Israel Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia Biosimilar Monoclonal Antibody Market Size, 2017-2028
  6.7.5 UAE Biosimilar Monoclonal Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biocon
  7.1.1 Biocon Corporate Summary
  7.1.2 Biocon Business Overview
  7.1.3 Biocon Biosimilar Monoclonal Antibody Major Product Offerings
  7.1.4 Biocon Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.1.5 Biocon Key News
7.2 Accord Healthcare
  7.2.1 Accord Healthcare Corporate Summary
  7.2.2 Accord Healthcare Business Overview
  7.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Major Product Offerings
  7.2.4 Accord Healthcare Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.2.5 Accord Healthcare Key News
7.3 AET Biotech
  7.3.1 AET Biotech Corporate Summary
  7.3.2 AET Biotech Business Overview
  7.3.3 AET Biotech Biosimilar Monoclonal Antibody Major Product Offerings
  7.3.4 AET Biotech Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.3.5 AET Biotech Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Biosimilar Monoclonal Antibody Major Product Offerings
  7.4.4 Amgen Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Celltrion
  7.5.1 Celltrion Corporate Summary
  7.5.2 Celltrion Business Overview
  7.5.3 Celltrion Biosimilar Monoclonal Antibody Major Product Offerings
  7.5.4 Celltrion Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.5.5 Celltrion Key News
7.6 Reddy's Laboratories
  7.6.1 Reddy's Laboratories Corporate Summary
  7.6.2 Reddy's Laboratories Business Overview
  7.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Major Product Offerings
  7.6.4 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.6.5 Reddy's Laboratories Key News
7.7 Hospira
  7.7.1 Hospira Corporate Summary
  7.7.2 Hospira Business Overview
  7.7.3 Hospira Biosimilar Monoclonal Antibody Major Product Offerings
  7.7.4 Hospira Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.7.5 Hospira Key News
7.8 3SBio
  7.8.1 3SBio Corporate Summary
  7.8.2 3SBio Business Overview
  7.8.3 3SBio Biosimilar Monoclonal Antibody Major Product Offerings
  7.8.4 3SBio Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.8.5 3SBio Key News
7.9 Allergan
  7.9.1 Allergan Corporate Summary
  7.9.2 Allergan Business Overview
  7.9.3 Allergan Biosimilar Monoclonal Antibody Major Product Offerings
  7.9.4 Allergan Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.9.5 Allergan Key News
7.10 Alvartis
  7.10.1 Alvartis Corporate Summary
  7.10.2 Alvartis Business Overview
  7.10.3 Alvartis Biosimilar Monoclonal Antibody Major Product Offerings
  7.10.4 Alvartis Biosimilar Monoclonal Antibody Revenue in Global Market (2017-2022)
  7.10.5 Alvartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biosimilar Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 2. Biosimilar Monoclonal Antibody Market Drivers in Global Market
Table 3. Biosimilar Monoclonal Antibody Market Restraints in Global Market
Table 4. Key Players of Biosimilar Monoclonal Antibody in Global Market
Table 5. Top Biosimilar Monoclonal Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilar Monoclonal Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilar Monoclonal Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilar Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 Biosimilar Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilar Monoclonal Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilar Monoclonal Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilar Monoclonal Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilar Monoclonal Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilar Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilar Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Biocon Corporate Summary
Table 31. Biocon Biosimilar Monoclonal Antibody Product Offerings
Table 32. Biocon Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 33. Accord Healthcare Corporate Summary
Table 34. Accord Healthcare Biosimilar Monoclonal Antibody Product Offerings
Table 35. Accord Healthcare Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 36. AET Biotech Corporate Summary
Table 37. AET Biotech Biosimilar Monoclonal Antibody Product Offerings
Table 38. AET Biotech Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Biosimilar Monoclonal Antibody Product Offerings
Table 41. Amgen Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Celltrion Corporate Summary
Table 43. Celltrion Biosimilar Monoclonal Antibody Product Offerings
Table 44. Celltrion Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 45. Reddy's Laboratories Corporate Summary
Table 46. Reddy's Laboratories Biosimilar Monoclonal Antibody Product Offerings
Table 47. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Hospira Corporate Summary
Table 49. Hospira Biosimilar Monoclonal Antibody Product Offerings
Table 50. Hospira Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 51. 3SBio Corporate Summary
Table 52. 3SBio Biosimilar Monoclonal Antibody Product Offerings
Table 53. 3SBio Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 54. Allergan Corporate Summary
Table 55. Allergan Biosimilar Monoclonal Antibody Product Offerings
Table 56. Allergan Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)
Table 57. Alvartis Corporate Summary
Table 58. Alvartis Biosimilar Monoclonal Antibody Product Offerings
Table 59. Alvartis Biosimilar Monoclonal Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biosimilar Monoclonal Antibody Segment by Type in 2021
Figure 2. Biosimilar Monoclonal Antibody Segment by Application in 2021
Figure 3. Global Biosimilar Monoclonal Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilar Monoclonal Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Monoclonal Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2021
Figure 8. By Type - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 12. US Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 24. China Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilar Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilar Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Biocon Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Accord Healthcare Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AET Biotech Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celltrion Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hospira Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. 3SBio Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Allergan Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Alvartis Biosimilar Monoclonal Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)